Contribution of specific ceramides to obesity-associated metabolic diseases
P Hammerschmidt, JC Brüning - Cellular and Molecular Life Sciences, 2022 - Springer
Ceramides are a heterogeneous group of bioactive membrane sphingolipids that play
specialized regulatory roles in cellular metabolism depending on their characteristic fatty …
specialized regulatory roles in cellular metabolism depending on their characteristic fatty …
Ceramide metabolism in cardiovascular disease: a network with high therapeutic potential
A Zietzer, P Düsing, L Reese, G Nickenig… - … , and Vascular Biology, 2022 - Am Heart Assoc
Growing evidence suggests that ceramides play an important role in the development of
atherosclerotic and valvular heart disease. Ceramides are biologically active sphingolipids …
atherosclerotic and valvular heart disease. Ceramides are biologically active sphingolipids …
Ceramide acyl chain length and its relevance to intracellular lipid regulation
QWC Ho, X Zheng, Y Ali - International journal of molecular sciences, 2022 - mdpi.com
Ceramides are a class of sphingolipids which are implicated in skin disorders, obesity, and
other metabolic diseases. As a class with pleiotropic effects, recent efforts have centred on …
other metabolic diseases. As a class with pleiotropic effects, recent efforts have centred on …
Sphingolipids and atherosclerosis: the dual role of ceramide and sphingosine-1-phosphate
M Piccoli, F Cirillo, A Ghiroldi, P Rota, S Coviello… - Antioxidants, 2023 - mdpi.com
Sphingolipids are bioactive molecules that play either pro-and anti-atherogenic roles in the
formation and maturation of atherosclerotic plaques. Among SLs, ceramide and sphingosine …
formation and maturation of atherosclerotic plaques. Among SLs, ceramide and sphingosine …
High‐fat diets: You are what you eat…. your extracellular vesicles too!
Recent works indicate that the lipid composition of extracellular vesicles (EVs) can modify
their biological functions and their incorporation into recipient cells. In particular high‐fat …
their biological functions and their incorporation into recipient cells. In particular high‐fat …
Analysis of circulating ceramides and hexosylceramides in patients with coronary artery disease and type II diabetes mellitus
P Düsing, NN Heinrich, B Al-Kassou, K Gutbrod… - BMC Cardiovascular …, 2023 - Springer
Background Cardiovascular disease (CVD) remains the leading cause of death worldwide.
The main driving force behind this association is coronary artery disease (CAD), the …
The main driving force behind this association is coronary artery disease (CAD), the …
Transcriptomics analysis reveals potential regulatory role of nSMase2 (Smpd3) in nervous system development and function of middle‐aged mouse brains
Z Zhu, TS McClintock, E Bieberich - Genes, Brain and Behavior, 2024 - Wiley Online Library
Abstract Neutral sphingomyelinase‐2 (nSMase2), gene name sphingomyelin
phosphodiesterase‐3 (Smpd3), is a key regulatory enzyme responsible for generating the …
phosphodiesterase‐3 (Smpd3), is a key regulatory enzyme responsible for generating the …
Protective Activity of Alpha‐Mangostin against UVB‐Induced Injury in HaCaT Cells by Modulating the Ceramide and MAPK and NF‐κB Signaling Pathways
J Jin, Y Bao, Y Wang, H Zheng, H Guo… - Journal of Food …, 2023 - Wiley Online Library
This study investigated the potential protective effects of alpha‐mangostin (α‐MG) on
ultraviolet B (UVB)‐induced damage in HaCaT cells. The results showed that α‐MG less …
ultraviolet B (UVB)‐induced damage in HaCaT cells. The results showed that α‐MG less …
Novel insights into the modulation of the voltage-gated potassium channel KV1. 3 activation gating by membrane ceramides
BC Szabo, M Szabo, P Nagy, Z Varga, G Panyi… - Journal of Lipid …, 2024 - jlr.org
Membrane lipids extensively modulate the activation gating of voltage-gated potassium
channels (KV), however, much less is known about the mechanisms of ceramide and …
channels (KV), however, much less is known about the mechanisms of ceramide and …
Plasma ceramides as biomarkers for microvascular disease and clinical outcomes in diabetes and myocardial infarction
DL Junqueira, AB Cavalcanti, JMF Sallum… - Clinical Diabetes and …, 2024 - Springer
Background Ceramides have recently been identified as novel biomarkers associated with
diabetes mellitus (DM) and major adverse cardiac and cerebrovascular events (MACCE) …
diabetes mellitus (DM) and major adverse cardiac and cerebrovascular events (MACCE) …